CJ 바이오사이언스

311690KOSDAQ자연과학 및 공학 연구개발업

49.8 / 100

Reference Date: 2026-06-10

Financial Score19.0 / 40

News Sentiment16.8 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Plunged 39.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CJ BioScience operates core businesses including AI-powered microbiome analysis platforms (Ez-Mx®) for drug development, microbial genome analysis solutions, and health & wellness services (e.g., GUT INSIDE, SMILE GUT). The company has strategically shifted focus toward health & wellness, expanding consumer-accessible AI-based gut health diagnostic services in 2025. The majority of revenue comes from its microbiome genome analysis platform, EzBioCloud.

Number of Employees

102people

Average Salary

79.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 62.704.0Point

PBR

1.14Industry Average 3.247.0Point

Half of industry avg (excellent)

ROE

-36.54Industry Average -32.093.5Point

In line with industry avg

Debt Ratio

7.72Industry Average 7.312.0Point

Higher than industry avg (caution)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼15.7% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲10.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -39.5% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 2Neutral 1Negative 2Average Sentiment Score 67

Positive
“대변 보내면 AI가 영양제 골라준다”…CJ바사, GLP-1 시대 정조...
CJ 바이오사이언스의 AI 기반 개인 맞춤형 영양제 추천 서비스 출시로 미래 지향적인 기술 혁신을 보여주며 긍정적인 시장 반응 예상.
Positive
CJ바이오사이언스, 마이크로바이옴 상용화 속도…웰니스 시장 조준
CJ바이오사이언스의 마이크로바이옴 연구 성과가 국제 컨퍼런스에서 주목받아 웰니스 시장 진출에 긍정적 영향 기대.
Neutral
CJ바이오사이언스, 마이크로바이옴 학술 대회 참가
CJ바이오사이언스가 국제 학술 대회에 참가하여 마이크로바이옴 연구를 공유하였으나, 직접적인 주식 영향은 제한적이다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 4,675Won52-week high 11,30052-week low 4,675

1-month return0.0Point

1m -39.68% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-01
Neutral분기보고서 (2026.03)2026-05-15
Neutral투자판단관련주요경영사항(임상시험계획자진취하등)2026-05-12